POAI: Gunggunge utang jangka dawa Predictive Oncology

The market trend for the long-term liabilities of Predictive Oncology (POAI), which stands at 0.00, is accompanied by the implementation of green IT solutions to combat cancer and minimize server costs. Predictive Oncology relies on digital modeling that reduces the number of physical chemical tests and the volume of biohazardous waste. The business is based on the expansion of PeDAL software, which aims to capture the high-precision therapy forecasting market through B2B subscriptions.

This indicator captures the total volume of long-term liabilities, reflecting the dynamics of borrowed capital and the degree of business financial autonomy during long-term planning. Rising debt loads, coupled with the limited pricing power of Predictive Oncology (POAI) in the AI analytics segment, increase liquidity risks, allowing for an assessment of the company's stability through the current level of the enterprise's long-term debt.